June 14, 2021

data on the Delta variant in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

As part of the EAVE II project, researchers from the Universities of Edinburgh and Strathclyde along with Public Health Scotland have analysed data on the delta (B.1.617.2) variant, looking at cases, risk of hospitalisation and vaccine effectiveness and how this compares to the alpha (B.1.1.7) variant. They have published their results as a research letter in The Lancet.

Note from The Lancet: Research letters published in the Correspondence section include research findings and are externally peer-reviewed. Unlike Articles containing original data, research letters are shorter and the research they contain is usually preliminary, exploratory, or reporting on early findings.

Speakers included:

Prof Aziz Sheikh, Director of the Usher Institute, and Professor of Primary Care Research & Development, University of Edinburgh

Prof Chris Robertson, Professor of Public Health Epidemiology, University of Strathclyde

Dr Jim McMenamin, National Covid-19 Incident Director, Public Health Scotland

This Briefing was accompanied by an SMC Roundup of Comments.